Cardiology

Doctors Hospital at Renaissance is currently conducting the following trials in cardiology:

Status Clinical Trial # Title of Study Location Contact Number Learn More Principal Investigator
Closed for Enrollment NCT01975376 The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-1) Doctors Hospital at Renaissance 956-362-2378 Click Here for more information Mahesh Changlani, MD
Closed for Enrollment NCT01975389 The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-2) Doctors Hospital at Renaissance 956-362-2378 Click Here for more information Mahesh Changlani, MD
Open for Enrollment NCT02504216 Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD) Doctors Hospital at Renaissance 956-362-2384 Click Here for more information Mahesh Changlani, MD

Doctors Hospital at Renaissance

 © Copyright. All rights reserved.

5501 S. McColl Rd. Edinburg Texas 78539 | (956) 362-8677 | 956-DOCTORS

As required by the 2012 Hospital Outpatient Prospective Payment; Ambulatory Surgical Center Payment;
Hospital Value-Based Purchasing Program; Physician Self-Referral; and Patient Notification Requirements
in Provider Agreements
final rule, Doctors Hospital at Renaissance, Ltd is disclosing that it is seeking an expansion
exception under Section 6001 of the Affordable Care Act of 2010.

Doctors Hospital at Renaissance proudly meets the federal definition of a "physician-owned hospital" (42 CFR § 489.3). As required by law, a list of the hospital's physician owners and investors is available at here. DHR, Ltd. and its affiliated entities comply with applicable Federal civil rights laws and do not discriminate on the basis of race, color, national origin, age, disability, or sex.